• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可注射成纤维细胞生长因子-2 凝聚体用于持续血管生成。

Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis.

机构信息

Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13444-9. doi: 10.1073/pnas.1110121108. Epub 2011 Aug 1.

DOI:10.1073/pnas.1110121108
PMID:21808045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3158148/
Abstract

Enhancing the maturity of the newly formed blood vessels is critical for the success of therapeutic angiogenesis. The maturation of vasculature relies on active participation of mural cells to stabilize endothelium and a basal level of relevant growth factors. We set out to design and successfully achieved robust angiogenesis using an injectable polyvalent coacervate of a polycation, heparin, and fibroblast growth factor-2 (FGF2). FGF2 was loaded into the coacervate at nearly 100% efficiency. In vitro assays demonstrated that the matrix protected FGF2 from proteolytic degradations. FGF2 released from the coacervate was more effective in the differentiation of endothelial cells and chemotaxis of pericytes than free FGF2. One injection of 500 ng of FGF2 in the coacervate elicited comprehensive angiogenesis in vivo. The number of endothelial and mural cells increased significantly, and the local tissue contained more and larger blood vessels with increased circulation. Mural cells actively participated during the whole angiogenic process: Within 7 d of the injection, pericytes were recruited to close proximity of the endothelial cells. Mature vasculature stabilized by vascular smooth muscle cells persisted till at least 4 wk. On the other hand, bolus injection of an identical amount of free FGF2 induced weak angiogenic responses. These results demonstrate the potential of polyvalent coacervate as a new controlled delivery platform.

摘要

提高新形成血管的成熟度对于治疗性血管生成的成功至关重要。血管成熟依赖于壁细胞的积极参与,以稳定内皮细胞和相关生长因子的基础水平。我们设计并成功地使用多价凝聚体实现了强大的血管生成,该凝聚体由聚阳离子、肝素和成纤维细胞生长因子 2(FGF2)组成。FGF2 以接近 100%的效率加载到凝聚体中。体外实验表明,基质保护 FGF2 免受蛋白水解降解。与游离 FGF2 相比,从凝聚体中释放的 FGF2 更有效地促进内皮细胞分化和周细胞趋化性。在凝聚体中注射 500 ng 的 FGF2 可引发体内全面的血管生成。内皮细胞和壁细胞的数量显著增加,局部组织含有更多和更大的血管,循环增加。壁细胞在整个血管生成过程中积极参与:在注射后的 7 天内,周细胞被募集到内皮细胞的附近。由血管平滑肌细胞稳定的成熟血管至少持续到 4 周。另一方面,相同数量的游离 FGF2 的单次注射引起了较弱的血管生成反应。这些结果表明多价凝聚体作为一种新的控制释放平台具有潜力。

相似文献

1
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis.可注射成纤维细胞生长因子-2 凝聚体用于持续血管生成。
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13444-9. doi: 10.1073/pnas.1110121108. Epub 2011 Aug 1.
2
Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.基于肝素的凝聚层对成纤维细胞生长因子-2和白细胞介素-10的可控双重递送协同增强缺血性心脏修复。
Biomaterials. 2015 Dec;72:138-51. doi: 10.1016/j.biomaterials.2015.08.050. Epub 2015 Sep 2.
3
Heparin-Based Coacervate of FGF2 Improves Dermal Regeneration by Asserting a Synergistic Role with Cell Proliferation and Endogenous Facilitated VEGF for Cutaneous Wound Healing.基于肝素的FGF2凝聚层通过与细胞增殖和内源性促进VEGF协同作用促进皮肤伤口愈合,改善皮肤再生。
Biomacromolecules. 2016 Jun 13;17(6):2168-77. doi: 10.1021/acs.biomac.6b00398. Epub 2016 May 26.
4
The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium.成纤维细胞生长因子-2 肝素共凝聚体对梗死心肌瘢痕形成的影响。
Biomaterials. 2013 Feb;34(6):1747-56. doi: 10.1016/j.biomaterials.2012.11.019. Epub 2012 Dec 2.
5
Concurrent and Sustained Delivery of FGF2 and FGF9 from Electrospun Poly(ester amide) Fibrous Mats for Therapeutic Angiogenesis.通过静电纺聚(酯酰胺)纤维垫同时持续递送FGF2和FGF9用于治疗性血管生成
Tissue Eng Part A. 2016 Apr;22(7-8):584-96. doi: 10.1089/ten.TEA.2015.0493. Epub 2016 Mar 31.
6
Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis.使用肝素结合纤维蛋白递送达碱性成纤维细胞生长因子促进治疗性血管生成。
Tissue Eng Part A. 2010 Jun;16(6):2113-9. doi: 10.1089/ten.TEA.2009.0673.
7
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.炎性细胞和趋化因子维持 FGF2 诱导的血管生成。
Eur Cytokine Netw. 2009 Jun;20(2):39-50. doi: 10.1684/ecn.2009.0155.
8
LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.LHT7,一种化学修饰的肝素,通过阻断 VEGF、FGF2 和 PDGF-B 信号通路来抑制血管生成的多个阶段。
Biomaterials. 2015 Jan;37:271-8. doi: 10.1016/j.biomaterials.2014.10.004. Epub 2014 Oct 28.
9
FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages.皮下基质胶栓的FGF2依赖性新生血管形成由骨髓来源的周细胞和巨噬细胞启动。
Development. 2008 Feb;135(3):523-32. doi: 10.1242/dev.002071. Epub 2008 Jan 2.
10
Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.在同时含有碱性成纤维细胞生长因子2(FGF2)和血管内皮生长因子(VEGF)的脱细胞胶原-肝素支架中,血管生成增加且血管成熟。
Biomaterials. 2007 Feb;28(6):1123-31. doi: 10.1016/j.biomaterials.2006.10.029. Epub 2006 Nov 20.

引用本文的文献

1
Biomolecular Condensates as Emerging Biomaterials: Functional Mechanisms and Advances in Computational and Experimental Approaches.作为新兴生物材料的生物分子凝聚物:功能机制以及计算与实验方法的进展
Adv Mater. 2025 Sep;37(36):e10115. doi: 10.1002/adma.202510115. Epub 2025 Aug 13.
2
The role of Genipin crosslinked extracellular matrix loaded bFGF in the repair of peripheral nerve injury.京尼平交联的负载碱性成纤维细胞生长因子的细胞外基质在周围神经损伤修复中的作用
BMC Biotechnol. 2025 Jul 24;25(1):76. doi: 10.1186/s12896-025-01015-y.
3
Material surface conjugated with fibroblast growth factor-2 for pluripotent stem cell culture and differentiation.与成纤维细胞生长因子-2偶联的材料表面用于多能干细胞培养和分化。
Regen Biomater. 2025 Jan 2;12:rbaf003. doi: 10.1093/rb/rbaf003. eCollection 2025.
4
Form Equals Function: Influence of Coacervate Architecture on Drug Delivery Applications.形式决定功能:凝聚体形貌对药物传递应用的影响。
ACS Biomater Sci Eng. 2024 Nov 11;10(11):6766-6789. doi: 10.1021/acsbiomaterials.4c01105. Epub 2024 Oct 18.
5
Design Rules for the Sequestration of Viruses into Polypeptide Complex Coacervates.将病毒隔离到多肽复合凝聚层中的设计规则
Biomacromolecules. 2024 Feb 12;25(2):741-753. doi: 10.1021/acs.biomac.3c00938. Epub 2023 Dec 16.
6
Enhanced pericyte-endothelial interactions through NO-boosted extracellular vesicles drive revascularization in a mouse model of ischemic injury.通过增强型 NO 外泌体促进血管周细胞-内皮细胞相互作用,促进缺血性损伤小鼠模型中的血管新生。
Nat Commun. 2023 Nov 13;14(1):7334. doi: 10.1038/s41467-023-43153-x.
7
Engineered hydrogels for peripheral nerve repair.用于周围神经修复的工程水凝胶。
Mater Today Bio. 2023 May 19;20:100668. doi: 10.1016/j.mtbio.2023.100668. eCollection 2023 Jun.
8
Feasibility of Coacervate-Like Nanostructure for Instant Drug Nanoformulation.凝聚体样纳米结构用于即时药物纳米制剂的可行性。
ACS Appl Mater Interfaces. 2023 Apr 12;15(14):17485-17494. doi: 10.1021/acsami.2c21586. Epub 2023 Mar 28.
9
Chitosan nanoparticle loaded by epidermal growth factor as a potential protein carrier for wound healing: In vitro and in vivo studies.壳聚糖纳米颗粒负载表皮生长因子作为一种有潜力的蛋白载体用于创伤愈合:体外和体内研究。
IET Nanobiotechnol. 2023 May;17(3):204-211. doi: 10.1049/nbt2.12116. Epub 2023 Feb 3.
10
Peptide-based coacervates in therapeutic applications.基于肽的凝聚物在治疗应用中的研究
Front Bioeng Biotechnol. 2023 Jan 4;10:1100365. doi: 10.3389/fbioe.2022.1100365. eCollection 2022.

本文引用的文献

1
A [polycation:heparin] complex releases growth factors with enhanced bioactivity.一种[多阳离子:肝素]复合物释放具有增强生物活性的生长因子。
J Control Release. 2011 Mar 10;150(2):157-63. doi: 10.1016/j.jconrel.2010.11.025. Epub 2010 Nov 29.
2
A defined glycosaminoglycan-binding substratum for human pluripotent stem cells.一种用于人类多能干细胞的特定糖胺聚糖结合基质。
Nat Methods. 2010 Dec;7(12):989-94. doi: 10.1038/nmeth.1532. Epub 2010 Nov 14.
3
A blue spectral shift of the hemoglobin soret band correlates with the age (time since deposition) of dried bloodstains.血红蛋白 soret 带的蓝移与血斑的年龄(沉积时间)相关。
PLoS One. 2010 Sep 20;5(9):e12830. doi: 10.1371/journal.pone.0012830.
4
Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain.从外向内的分隔:脑外的细胞基质和功能微区。
Trends Neurosci. 2010 Nov;33(11):503-12. doi: 10.1016/j.tins.2010.08.003.
5
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization.注射型多种生长因子释放支架与细胞治疗相结合作为增强组织血管新生的一种先进方式。
Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1897-904. doi: 10.1161/ATVBAHA.110.207928. Epub 2010 Aug 5.
6
Cell signaling by receptor tyrosine kinases.受体酪氨酸激酶的细胞信号转导。
Cell. 2010 Jun 25;141(7):1117-34. doi: 10.1016/j.cell.2010.06.011.
7
Control growth factor release using a self-assembled [polycation:heparin] complex.使用自组装[聚阳离子:肝素]复合物控制生长因子的释放。
PLoS One. 2010 Jun 8;5(6):e11017. doi: 10.1371/journal.pone.0011017.
8
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.肝素衍生的硫酸乙酰肝素模拟物调节炎症和癌症中的硫酸乙酰肝素蛋白相互作用。
Matrix Biol. 2010 Jul;29(6):442-52. doi: 10.1016/j.matbio.2010.04.003. Epub 2010 Apr 21.
9
A critical review of clinical arteriogenesis research.临床动脉生成研究的批判性回顾。
J Am Coll Cardiol. 2009 Dec 29;55(1):17-25. doi: 10.1016/j.jacc.2009.06.058.
10
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors.联合递送血管生成和肌生成因子实现功能性肌肉再生。
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3287-92. doi: 10.1073/pnas.0903875106. Epub 2009 Dec 4.